The DISCOVER Study

Starting soon · Not applicable

Conditions studied: Cancer, Cancer Diagnosis

In brief

The purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer. The name of the screening blood test being studied is: -GRAIL Galleri MCED test

Key facts

Study ID

NCT07390643

Run by

Dana-Farber Cancer Institute

People needed

100

Starts

2026-07-01

Expected to finish

2028-01-31

Last updated by the study team

2026-02-05

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Be at least 22 years old
• Have signs and symptoms suggestive of cancer and/or have imaging related to signs and symptoms of cancer being evaluated in the Cancer Diagnostic Service clinic

You may not qualify if…

• Individuals diagnosed with invasive malignancy within 3 years of enrollment
• Individuals with active cancer requiring active therapeutic intervention at the time of participation (hormone therapy for breast/prostate cancer is considered acceptable and will not preclude participation)

Where it is running

• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.